Sun Pharma Q2 Results: Net profit jumps 28% to Rs 3,040 crore on higher sales
Sun Pharma reported a 28% year-on-year (YoY) jump in net profit to Rs 3040 crore in Q2FY25 led by higher sales growth in domestic formulation and global specialty portfolio.
The company reported net profit of Rs 2375.5 crore during the corresponding quarter of the previous year.
Revenue rose 10.5% YoY to Rs. 13,264 crore in Q2FY25.
The earnings for interest, tax, depreciation and ammortisation (EBITDA) rose 23.9% to Rs. 3939 crore in Q2, and EBITDA margins gained 350 basis points YoY to 29.6%.
India formulation sales rose 11% YoY to Rs. 4265.2 crore in Q2FY25. India accounts for 32% of Sun Pharma sales.
Stock Trading
ROC Made Easy: Master Course for ROC Stock Indicator
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Stock Investing Made Easy: Beginner's Stock Market Investment Course
By — elearnmarkets, Financial Education by StockEdge
Stock Trading
Dow Theory Made Easy
By — Vishal Mehta, Independent Systematic Trader
Stock Trading
RSI Made Easy: RSI Trading Course
By — Souradeep Dey, Equity and Commodity Trader, Trainer
Stock Trading
Options Trading Made Easy: Options Trading Course
By — Anirudh Saraf, Founder- Saraf A & Associates, Chartered Accountant
Stock Trading
Heikin Ashi Trading Tactics: Master the Art of Trading
By — Dinesh Nagpal, Full Time Trader, Ichimoku & Trading Psychology Expert
Stock Trading
Algo Trading Made Easy
By — Vivek Gadodia, Partner at Dravyaniti Consulting and RBT Algo Systems
Stock Trading
Options Scalping Made Easy
By — Sivakumar Jayachandran, Ace Scalper
Stock Trading
A2Z
